Non-muscle Invasive Bladder Cancer Clinical Trials in Baltimore, Maryland

3 studies are recruiting for non-muscle invasive bladder cancer in Baltimore, Maryland right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

    The goal of the study is to learn about the safety of Sacituzumab Tirumotecan and if people can tolerate it when given in the bladder and find the highest dose that people can take without having certain problems. Researchers will then choose a dose level of Sacituzumab Tirumotecan to use in future…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Johns Hopkins University ( Site 0055), Baltimore, Maryland
    Locations
    13 in total
    Run by
    Merck Sharp & Dohme LLC

    See if you can join NCT06637423 on ClinicalTrials.gov

  2. A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

    The purpose of this study is to compare the effectiveness of different FDA-approved/NCCN-recommended drug treatments for NMIBC. In particular, the FDA-approved drug nadofaragene firadenovec will be compared to usual care with other NCCN-recommended standard treatments for NMIBC (gemcitabine with or…

    Stage
    Phase 3
    Ages
    21 and older
    Site
    Johns Hopkins University (Data Collection Only), Baltimore, Maryland
    Locations
    9 in total
    Run by
    Memorial Sloan Kettering Cancer Center

    See if you can join NCT06929286 on ClinicalTrials.gov

  3. LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

    This study will evaluate the safety and efficacy of intravesical administration of detalimogene (EG-70) in the bladder and its effect on bladder tumors in patients with NMIBC. This study study consists of two phases; a Phase 1 dose-escalation to establish safety and recommended the phase 2 dose, fo…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    John Hopkins Hospital, Baltimore, Maryland
    Locations
    102 in total
    Run by
    enGene, Inc.

    See if you can join NCT04752722 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.